Terms: = Breast cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
223 results:
1. Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative breast cancer: A Systematic Review.
Almeida-Ferreira C; Marto CM; Carmo C; Almeida-Ferreira J; Frutuoso C; Carvalho MJ; Botelho MF; Laranjo M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542225
[TBL] [Abstract] [Full Text] [Related]
2. Conditional generative adversarial network driven radiomic prediction of mutation status based on magnetic resonance imaging of breast cancer.
Huang ZH; Chen L; Sun Y; Liu Q; Hu P
J Transl Med; 2024 Mar; 22(1):226. PubMed ID: 38429796
[TBL] [Abstract] [Full Text] [Related]
3. Performance analysis of data resampling on class imbalance and classification techniques on multi-omics data for cancer classification.
Yang Y; Mirzaei G
PLoS One; 2024; 19(2):e0293607. PubMed ID: 38422094
[TBL] [Abstract] [Full Text] [Related]
4. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract] [Full Text] [Related]
5. Developing questions to assess and measure patients' perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study.
Tawfik B; Jacobson K; Brown-Glaberman U; Kosich M; Van Horn ML; Nemunaitis J; Dayao Z; Pankratz VS; Sussman AL; Guest DD
Clin Exp Med; 2024 Feb; 24(1):36. PubMed ID: 38353722
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.
Ido M; Fujii K; Mishima H; Kubo A; Saito M; Banno H; Ito Y; Goto M; Ando T; Mouri Y; Kousaka J; Imai T; Nakano S
BMC Cancer; 2024 Jan; 24(1):85. PubMed ID: 38229073
[TBL] [Abstract] [Full Text] [Related]
7. [News in breast oncology genetics for female and male population].
Taris N; Luporsi E; Osada M; Thiblet M; Mathelin C
Gynecol Obstet Fertil Senol; 2024 Mar; 52(3):149-157. PubMed ID: 38190969
[TBL] [Abstract] [Full Text] [Related]
8. Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular breast cancer.
Giunta EF; Arrichiello G; Pappalardo A; Federico P; Petrillo A
Cancer Treat Res; 2023; 188():89-104. PubMed ID: 38175343
[TBL] [Abstract] [Full Text] [Related]
9. Dose to Organ at Risk and its Characteristic Variation with the Clinically Used Different Prescription Levels for Early-stage Left-sided breast cancer.
Haldar S; Sarkar B; Dixit A
Clin Oncol (R Coll Radiol); 2024 Jan; 36(1):21-29. PubMed ID: 38040550
[TBL] [Abstract] [Full Text] [Related]
10. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
[TBL] [Abstract] [Full Text] [Related]
11. Effects of exercise training on cancer patients undergoing neoadjuvant treatment: A systematic review.
Malveiro C; Correia IR; Cargaleiro C; Magalhães JP; de Matos LV; Hilário S; Sardinha LB; Cardoso MJ
J Sci Med Sport; 2023 Nov; 26(11):586-592. PubMed ID: 37696693
[TBL] [Abstract] [Full Text] [Related]
12. Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide.
Lapcik P; Sulc P; Janacova L; Jilkova K; Potesil D; Bouchalova P; Müller P; Bouchal P
Cell Mol Biol Lett; 2023 Aug; 28(1):68. PubMed ID: 37620794
[TBL] [Abstract] [Full Text] [Related]
13. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
[TBL] [Abstract] [Full Text] [Related]
14. Effectiveness of Long-Term Opioid Therapy for Chronic Pain in an Outpatient Palliative Medicine Clinic.
Kollas CD; Ruiz K; Laughlin A
J Palliat Med; 2024 Jan; 27(1):31-38. PubMed ID: 37552851
[No Abstract] [Full Text] [Related]
15. Clinical evaluation of atlas-based auto-segmentation in breast and nodal radiotherapy.
Welgemoed C; Spezi E; Riddle P; Gooding MJ; Gujral D; McLauchlan R; Aboagye EO
Br J Radiol; 2023 Sep; 96(1149):20230040. PubMed ID: 37493138
[TBL] [Abstract] [Full Text] [Related]
16. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.
Vellichirammal NN; Tan YD; Xiao P; Eudy J; Shats O; Kelly D; Desler M; Cowan K; Guda C
Hum Genomics; 2023 Jul; 17(1):64. PubMed ID: 37454130
[TBL] [Abstract] [Full Text] [Related]
17. cdh1 overexpression sensitizes TRAIL resistant breast cancer cells towards rhTRAIL induced apoptosis.
Tapadar P; Pal A; Ghosal N; Kumar B; Paul T; Biswas N; Pal R
Mol Biol Rep; 2023 Sep; 50(9):7283-7294. PubMed ID: 37422537
[TBL] [Abstract] [Full Text] [Related]
18. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
Yonekura S; Endo Y; Fujii H; Ishikawa M; Egawa G; Kabashima K
J Dermatol; 2023 Nov; 50(11):1493-1496. PubMed ID: 37400887
[TBL] [Abstract] [Full Text] [Related]
19. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract] [Full Text] [Related]
20. Synergism of FAK and ROS1 inhibitors in the treatment of
Gao J; Yao Y; Liu C; Xie X; Li D; Liu P; Wang Z; Zhang B; Ren R
Int J Biol Sci; 2023; 19(9):2711-2724. PubMed ID: 37324948
[No Abstract] [Full Text] [Related]
[Next]
